• PMDAlliance Will Share ’emPowered!’ to Improve Doctor-Patient Communications
  • Gocovri Improves Dyskinesia in Parkinson’s Patients Over Long Term, Phase 3 Trial Shows
  • 10 Things People with Parkinson’s Love, Loathe, and Long for
  • New Brain PET Scanner Shows Promise for Earlier and Less Expensive Diagnosis of Parkinson’s
  • Voice-Based Technology to Detect Mental, Physical Disorders Receives US, Australian Patents
  • Neurodegenerative Disease Mechanisms May Begin Soon After Birth, Mouse Study Suggests
  • Phase 2 Study of Potential Oral Therapy for Parkinson’s Dementia, Anavex 2-73, Planned
  • Using Artificial Intelligence to Analyze Brain Cells May Revolutionize Research
  • #AAN2018 – Real-life Use Supports Nuplazid’s Safety, Efficacy in Treating Parkinson’s Psychosis
  • Walking Through the Valley of Shadows
  • Global Kinetics Gets Funding for Trial of Its Wearable Device for Recording Parkinson’s Movement Data
  • #AAN2018: Biogen’s BIIB054 Shows Positive Data in Phase 1 Parkinson’s Trial